1. Search Result
Search Result
Targets Recommended: NEDD8-activating Enzyme
Results for "


" in MCE Product Catalog:
Cat. No. Product Name Target Research Area
  • HY-P99024


    Inhibitory Antibodies Cancer
    Glofitamab (RO7082859) is a T-cell-engaging bispecific antibody possessing a novel 2:1 structure with bivalency for CD20 on B cells and monovalency for CD3 on T cells. Glofitamab leads to T-cell activation, proliferation, and tumor cell killing upon binding to CD20 on malignant cells. Glofitamab induces durable complete remissions in relapsed or refractory B-Cell lymphoma.